JCAD and endothelial dysfunction: We have recently identified JCAD as a negative regulator of Hippo signalling in endothelial cells, suggesting that JCAD may in part contribute to endothelial dysfunction by down-regulation of Hippo signalling, leading to increased YAP activity.3